Skip to main content
. Author manuscript; available in PMC: 2012 Dec 19.
Published in final edited form as: Mol Cancer Res. 2009 Jun 2;7(6):863–869. doi: 10.1158/1541-7786.MCR-08-0418

Figure 2. In the absence of Arf, MDM2-A does not alter survival, but does enhance T-cell lymphoma development.

Figure 2

(A) Kaplan-Meier survival curve for Arf-null (dashed line) and Mdm2-a/Arf-null (solid line). There was no significant difference in survival of these two groups of mice (p=0.497). (B) Tumor distribution in Arf-null (upper) and Mdm2-a/Arf-null (lower) displayed a marginally significant difference between the two groups (p=0.096). NST: Nerve Cell Tumor.